Basket study including patients with CRC, GEA, and HCC.The ORR was 41.67% in CPS ≥ 5 patients. Higher PFS in patients with CPS ≥ 5 high tumors and less tumor-associated macrophages and greater tumor-infiltrating CD4 T cells. The gene discussed is CD4; the disease is colorectal carcinoma.